Parviz Shamlou

Senior Vice President of Science and Technology

Parviz A. Shamlou is the Senior Vice President of Science & Technology at Abzena. Parviz has decades of experience in the design, development, and manufacturing of complex biologic programs. Specifically, Parviz is involved in many of our CMC activities with a focus on bioprocessing of therapeutic proteins and antibodies and associated modalities including fusion proteins, bisects and bifunctional antibodies, antibody-drug conjugates, vaccines as well as gene therapy and cell therapy.

Recently Pharmaceutical Technology® spoke with Parviz about the impact of the Biosecure Act on the bio/pharmaceutical industry, as well as the progress of continuous manufacturing in biopharma. You can read that article here.

Ask Our Expert

What is your biologic drug development challenge? Ask our expert today. We are ready to help.